Brought to you by:
Exploring the effectiveness of Topical Wound Oxygen therapy in diabetic foot and venous leg ulcers: ‘A new, different functionality that penetrates the wound’
This advertorial is sponsored by AOTI. Until about a decade and a half ago, vascular surgeon Alisha Oropallo, MD, could be counted among the skeptics. Back then, she says, topical wound oxygen therapy for nonhealing vascular wounds did not have…
Tackling inequities in venous care
During the 2024 American Venous Forum (AVF;March 3–6) in Tampa, Florida, multiple presenters discussed inequities in venous care with a focus on how to get more patients into research, how geographic and demographic factors determine care both pre- and post-COVID-19,…
The top 10 most popular Vascular Specialist stories of April 2024
In April, the most read stories from Vascular Specialist include new research on Chat generative pre-trained transformer (GPT) technology and its application within vascular surgery and training; SVS Vice President candidates are announced; a guest editorial on how open access…
Novel ultrasound-facilitated thrombectomy with microbubbles shows promise in acute porcine model for DVT treatment
Evaluation of the safety and performance of a novel pharmaco-mechanical procedure for acute deep vein thrombosis (DVT) in two pigs demonstrated a significant reduction in thrombus burden and vessel wall preservation, data from in vivo testing reveals. The SonoThrombectomy system…
Study hints at long-term cost-effectiveness of CDT and PMT over oral anticoagulation for moderate and severe PTS
During a presentation at the 2024 European Vascular Course (EVC; March 3–5) in Maastricht, The Netherlands, Anna Pouncey, MD, a clinical research fellow for vascular surgery at Imperial College London in London, England, presented findings from a study on the…
First-in-human study of Pounce thrombectomy system in acute iliofemoral DVT demonstrates 12-month PTS rate of 18%
Twelve-month outcomes from the Pounce venous thrombectomy system (Vetex Medical) first-in-human study evaluating its use in the treatment of acute iliofemoral deep vein thrombosis (DVT) recently published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVS-VL) demonstrated an…
Tackling DVT head on: Single-session, wall-to-wall thrombus removal with the ClotTriever BOLD
This advertorial is sponsored by Inari Medical. Several years ago, when Nicolas Mouawad, MD, division chief of vascular surgery at McLaren Health in Bay City, Michigan, was confronted with an emergency case of deep vein thrombosis (DVT) in which the…
CLOUT registry: Interim two-year rates of PTS ‘significantly lower’ than those in historical DVT studies
Rates of post-thrombotic syndrome (PTS) among deep vein thrombosis (DVT) patients treated with the ClotTriever thrombectomy system (Inari Medical) who are logged in the real-world CLOUT registry demonstrated “significant and sustained improvement” out to 24 months, according to interim two-year…
U.S. study highlights racial and ethnic disparities in the placement of ‘overused’ IVC filters
A nationwide U.S. study, recently published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVS-VL), showed that Black patients had the highest inferior vena cava (IVC) filter placement rate per 100,000 persons compared with white and Latino patients…
Mechanical thrombectomy demonstrates superior outcomes to anticoagulation in DVT patients, analysis of RCT and registry data shows
Mechanical thrombectomy using the ClotTriever device (Inari Medical) for iliofemoral deep vein thrombosis (DVT) was found to be “associated with significantly” lower Villalta scores and a lower incidence of post-thrombotic syndrome (PTS) out to 12 months compared with treatment using anticoagulation,…